Minimally Invasive Techniques in Ventral Hernioplasty

Status Not yet recruiting

Clinical Trial Summary

1. Review the surgical outcome of different techniques using extraperitoneal ventral hernia repair regarding postoperative pain. wound infection ,hospital stay , recurrence ,mesh migration and mesh induced visceral complications. 2. Reviewing advantages and drawbacks of each surgical technique regarding feasibility ,cost effectiveness and technical difficulties

Clinical Trial Description

The laparoscopic ventral hernia repair was first introduced by LeBlanc and Booth in the early 1990s . Since its introduction, it has continued to evolve and has become an important option in the hernia surgeon's armamentarium. However, only 27.4% of ventral hernia repairs are performed laparoscopically, likely because of the relatively advanced nature of this procedure and because all hernias may not be suitable for a laparoscopic approach. Using current techniques, numerous studies have documented the safety and efficacy of this approach. Some data suggest that the laparoscopic approach results in a shorter hospital stay and lower recurrence rates compared with open approaches. However, pain may still be significant after laparoscopic repairs and there are not significant advantages from this standpoint. Nonetheless, it is well accepted that the primary advantage of the laparoscopic approach is that wound infections are less frequent compared with open approaches .LeBlanc and Booth in 1993 first reported application of intra-peritoneal onlay mesh (IPOM) for ventral and incisional hernia, However the technique requires expensive fixation devices which may cause acute and chronic pain .The laparoscopic groin hernia repair using synthetic mesh in TEP or TAPP are acceptable surgical techniques today These techniques are rarely associated with mesh induced complications, the reason being extraperitoneal placement of synthetic mesh. It is apparent that despite great progress in mesh technology, nearly all types of meshes have been found to produce a varying level of adhesion or tissue reaction, regardless of the material and coating used. Preoperatively unpredictable, a mesh-induced visceral complication may occur in some patients to produce severe reaction or major mesh-related adverse events.The incitation to develop certain novel minimally invasive techniques that enables researchers to bring the mesh out of abdominal cavity has been an exciting trend in laparoscopic hernia repair. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06255314
Study type	Interventional
Source	Assiut University
Contact	mohamed badr
Phone	01060624371
Email	akhel93@yahoo.com
Status	Not yet recruiting
Phase	N/A
Start date	February 2024
Completion date	October 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06016426` - Mass Closure vs Layer by Layer Closure	N/A
Recruiting	`NCT05572021` - A Comparison of the Outcomes in Fortiva and Strattice Mesh	N/A
Completed	`NCT02263625` - Regional Differences In Indication for Ventral Hernia Repair
Completed	`NCT02292264` - Risk Factors and Complications of Ventral Hernia Repair
Completed	`NCT02263599` - Conservative Treatment For Ventral Hernia
Completed	`NCT01961687` - A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.	N/A
Completed	`NCT01325246` - Reoperation Rate Versus Clinical Recurrence After Ventral Hernia Repair	N/A
Completed	`NCT03283982` - Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM	N/A
Not yet recruiting	`NCT05526209` - Longitudinal Relaxing Incision as a Technique for Recurrence Prevention in Ventral Hernia
Completed	`NCT04438369` - Evaluation of Ultrasound-guided Erector Spinae Block for Postoperative Analgesia in Laprascopic Ventral Hernia Repair.	N/A
Recruiting	`NCT04173884` - Video-based Collaborative Learning to Improve Ventral Hernia Repair	N/A
Recruiting	`NCT02703662` - Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction	Phase 2/Phase 3
Completed	`NCT03938688` - Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation	N/A
Active, not recruiting	`NCT01719718` - The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair	N/A
Completed	`NCT03342040` - Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair	N/A
Completed	`NCT04150796` - Comparing eTEP and Laparoscopic Intraperitoneal Onlay Mesh (IPOM) for Ventral Hernias	N/A
Recruiting	`NCT03222102` - Ventral Hernia Prevention After Liver Transplantation	N/A
Completed	`NCT05610267` - Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair
Terminated	`NCT01794338` - The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients	N/A
Completed	`NCT01886963` - A Clinical Trial Using Spy Elite System in Planning Tissue Advancement Flaps After Ventral Hernia Repair	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.